IP Library Granted Patent US 7,919,487
Granted Patent B2
US 7,919,487 · App. 11/271,704 · Granted Apr 5, 2011

Heteroaryl compounds

Assignee: Synta Pharmaceuticals Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,919,487
App. No.
11/271,704
Granted
Apr 5, 2011
Kind
B2
Abstract

This invention relates to compounds of formula (I): their compositions and methods of use thereof. The compounds (and compositions) are useful in modulating IL-12 production and processes mediated by IL-12.

Claims (189)

1. A compound represented by formula (II):

or a pharmaceutically acceptable salt thereof, wherein:

V is N and Q and U are CR g ;

X 1 is selected from the group consisting of:

represents the point of attachment;

Y is (CH(R g )) m , C(O), C(NR), O, S, S(O), S(O) 2 , N(OR k ), N(R k ), or absent;

R 1 is a substituted or unsubstituted aryl or a substituted or unsubstituted heteroaryl, provided that R 1 is not tetrazolyl, o-methoxyphenyl, 3,4,5-trimethoxyphenyl, a substituted or unsubstituted 4,5-dihydro-1H-benzo[g]indazolyl, a substituted 5-oxo-1,2,3,9b-tetrahydro-pyrrolo[2,1-a]isoindolyl;

R 3 is R g , —C(O)R c , —OC(O)R c , —SC(O)R c , —NR k C(O)R c , —C(S)R c , —OC(S)R c , —SC(S)R c , —NR k C(S)R c , —C(NR)R c , —OC(NR)R c , —SC(NR)R c , —NR k C(NR)R c , —SO 2 R c , —S(O)R c , —NR k SO 2 R c , —OS(O) 2 R c , —OP(O)R c R c , or —P(O)R c R c ;

R 2 and R 4 for each occurrence, are independently, H, an optionally substituted alkyl, an optionally substituted alkylcarbonyl, —OR k , —SR k , —NR h R j , hydroxylalkyl, —C(O)R c , —OC(O)R c , —SC(O)R c , —NR k C(O)R c , —C(S)R c , —OC(S)R c , —SC(S)R c , —NR k C(S)R c , —C(NR)R c , —OC(NR)R c , —SC(NR)R c , —NR k C(NR)R c , —SO 2 R c , —S(O)R c , —NR k SO 2 R c , —OS(O) 2 R c , —OP(O)R c R c , —P(O)R c R c , halo, haloalkyl, aminoalkyl, mercaptoalkyl, cyano, nitro, nitroso, azide, an optionally substituted alkylcarbonylalkyl, an optionally substituted cyclyl, an optionally substituted cycloalkyl, an optionally substituted heterocyclyl, an optionally substituted heterocycloalkyl, an optionally substituted aryl, an optionally substituted aralkyl, an optionally substituted heteroaryl, an optionally substituted heteroaralkyl, or isothionitro; or R 2 and R 4 taken together are ═O, ═S, or ═NR;

R 6 is H or an alkyl;

R c , for each occurrence, is independently, H, an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cyclyl, an optionally substituted cycloalkyl, an optionally substituted heterocyclyl, an optionally substituted heterocycloalkyl, an optionally substituted aralkyl, an optionally substituted heteroaralkyl, an optionally substituted aryl, an optionally substituted heteroaryl, haloalkyl, —OR k , —SR k , —NR h R j , hydroxylalkyl, alkylcarbonylalkyl, mercaptoalkyl, aminoalkyl, sulfonylalkyl, sulfonylaryl, or thioalkoxy;

R d , for each occurrence, is independently, H or a halo;

R g , for each occurrence, is independently, H;

R h and R j , for each occurrence, are independently H, an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cyclyl, an optionally substituted cycloalkyl, an optionally substituted heterocyclyl, an optionally substituted heterocycloalkyl, an optionally substituted aralkyl, an optionally substituted heteroaralkyl, an optionally substituted aryl, an optionally substituted heteroaryl; or R h and R j taken together with the N to which they are attached is an optionally substituted heterocyclyl, an optionally substituted heterocycloalkyl, or an optionally substituted heteroaryl;

R k , for each occurrence, is independently H, an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted cyclyl, an optionally substituted cycloalkyl, an optionally substituted heterocyclyl, an optionally substituted heterocycloalkyl, an optionally substituted aralkyl, an optionally substituted heteroaralkyl, an optionally substituted aryl, an optionally substituted heteroaryl;

G is a Hydrazide; Hydrazone; Hydrazine; Hydroxylamine; Oxime; Amide; Ester; Carbonate; Carbamate; Thiocarbamate; —NR k —C(NR)—NR k ; —NR k —C(O)—NR k —; —NR k —C(S)—NR k —; —NR k —S(O) 2 —NR k —; Phosphoryl; an optionally substituted -Cyclyl-; an optionally substituted -Heterocyclyl-; an optionally substituted -Aryl-; an optionally substituted -Heteroaryl-; an optionally substituted -Heteroarylalkyl-; an optionally substituted -Heteroaryl—NR k -; an optionally substituted -Heteroaryl-S—; an optionally substituted -Heteroarylalkyl-O—; —Si(OR k ) 2 —; —B(OR k )—; —C(NR)—NR k —; —N(R k )—CR g R g —C(O)—; —C(O)—ON(R k )—; —C(O)—N(R k )O—; —C(S)—ON(R k )—; —C(S)—N(R k )O—; —C(N(R k ))—ON(R k )—; —C(N(R k ))—NR k O—; —OS(O) 2 —N(R k )N(R k )—; —OC(O)—N(R k )N(R k )—; —OC(S)—N(R k )N(R k )—; —OC(N(R k ))—N(R k )N(R k )—; —N(R k )N(R k )S(O) 2 O—; —N(R k )N(R k )C(S)O—; —N(R k )N(R k )C(N(R k ))O—; —OP(O)(R c )O—; —N(R k )P(O)(R c )O—; —OP(O)(R c )N(R k )—; —N(R k )P(O)(R c )N(R k )—; —P(O)(R c )O—; —P(O)(R c )N(R k )—; —N(R k )P(O)(R c )—; —OP(O)(R c )—; —O-alkyl-heterocyclyl-N(R k )—; —N(R k )CHR g C(O)N(R k )CHR g C(O)—; —N(R k )CHR g C(O)—; —N(R k )C(O)CHR g —; or —C(O)N(R k )CHR g C(O)—; each of which is optionally substituted; or G is absent;

q is 0, 1, 2, 3, or 4;

m, for each occurrence, is independently 1, 2, 3, 4, 5, 6, 7, or 8;

n, for each occurrence, is independently 0, 1, 2, 3, 4, 5, 6, or 7; and

p, for each occurrence, is independently 0, 1, or 2.

2. The compound of claim 1 , wherein R 1 is an optionally substituted naphthyl, an optionally substituted anthracenyl, an optionally substituted indanyl, an optionally substituted fluorenyl, an optionally substituted indenyl, an optionally substituted azulenyl, an optionally substituted pyridyl, an optionally substituted 1-oxo-pyridyl, an optionally substituted furanyl, an optionally substituted benzo[1,3]dioxolyl, an optionally substituted benzo[1,4]dioxinyl, an optionally substituted thienyl, an optionally substituted pyrrolyl, an optionally substituted oxazolyl, an optionally substituted imidazolyl, an optionally substituted thiazolyl, an optionally substituted isoxazolyl, an optionally substituted quinolinyl, an optionally substituted pyrazolyl, an optionally substituted isothiazolyl, an optionally substituted pyridazinyl, an optionally substituted pyrimidinyl, an optionally substituted pyrazinyl, an optionally substituted triazinyl, an optionally substituted triazolyl, an optionally substituted thiadiazolyl, an optionally substituted isoquinolinyl, an optionally substituted indazolyl, an optionally substituted benzoxazolyl, an optionally substituted benzofuryl, an optionally substituted indolizinyl, an optionally substituted imidazopyridyl, an optionally substituted benzimidazolyl, an optionally substituted benzothiazolyl, an optionally substituted benzothiadiazolyl, an optionally substituted benzoxadiazolyl, an optionally substituted indolyl, an optionally substituted tetrahydroindolyl, an optionally substituted azaindolyl, an optionally substituted indazolyl, an optionally substituted imidazopyridyl, an optionally substituted quinazolinyl, an optionally substituted purinyl, an optionally substituted pyrrolo[2,3]pyrimidinyl, an optionally substituted pyrazolo[3,4]pyrimidinyl, or an optionally substituted benzo(b)thienyl; or

R 1 is a phenyl group which is optionally substituted with one or more substituents selected from the group consisting of a halo, hydroxyl, amino, alkylamino, arylamino, dialkylamino, diarylamino, cyano, nitro, mercapto, mercapto, imino, formyl, carbamido, carbamyl, carboxyl, thioureido, thiocyanato, sulfoamido, sulfonylalkyl, sulfonylaryl, alkyl, alkenyl, alkynyl, cycloalkyl, cyclyl, aryl, aralkyl, heterocycloalkyl, heterocyclyl, heteroaryl, heteroaralkyl, haloalkyl, aryloxy, hydroxyl, hydroxylalkyl, alkylcarbonyl, alkylcarbonylalkyl, alkoxycarbonyl, alkylcarbonyloxy, aryloxycarbonyl, heteroaryloxy, heteroaryloxycarbonyl, mercaptoalkyl, arylsulfonyl, aminoalkyl, alkylcarbonylamino, alkylaminocarbonyl, alkoxycarbonylamino, arylamino-substituted aryl, arylalkylamino, aralkylaminocarbonyl, amido, alkylaminosulfonyl, arylaminosulfonyl, dialkylaminosulfonyl, alkylsulfonylamino, arylsulfonylamino, mercaptoalkoxy, SR 15 , S(O) 2 OR 15 , NR 15 R 16 , C 1 -C 2 perfluoroalkyl, C 1 -C 2 perfluoroalkoxy, 1,2-methylenedioxy, C(O)OR 15 , C(O)NR 15 R 16 , OC(O)NR 15 R 16 , NR 15 C(O)NR 15 R 16 , C(NR 16 )NR 15 R 16 , NR 15 C(NR 16 )NR 15 R 16 , S(O) 2 NR 15 R 16 , R 17 , C(O)H, C(O)R 17 , NR 15 C(O)R 17 , Si(R 15 ) 3 , OSi(R 15 ) 3 , Si(OH) 2 R 15 , B(OH) 2 , P(O)(OR 15 ) 2 , S(O)R 17 , or S(O) 2 R 17 ,

wherein each alkyl, alkenyl, alkynyl, cycloalkyl, cyclyl, aryl, aralkyl, heterocycloalkyl, heterocyclyl, heteroaryl, or heteroaralkyl, of each phenyl substituent of R 1 may be optionally substituted with alkyl, aryl, heteroaryl, halogen, hydroxyl, amino, mercapto, cyano, nitro, oxo (═O), thioxo (═S), or imino (═NR);

R 15 is independently hydrogen, C 1 -C 6 alkyl optionally substituted with cycloalkyl, aryl, heterocyclyl, or heteroaryl;

R 16 is independently hydrogen, C 3 -C 6 cycloalkyl, aryl, heterocyclyl, heteroaryl, C 1 -C 4 alkyl or C 1 -C 4 alkyl substituted with C 3 -C 6 cycloalkyl, aryl, heterocyclyl or heteroaryl; and

R 17 is independently C 3 -C 6 cycloalkyl, aryl, heterocyclyl, heteroaryl, C 1 -C 4 alkyl or C 1 -C 4 alkyl substituted with C 3 -C 6 cycloalkyl, aryl, heterocyclyl or heteroaryl;

wherein each C 3 -C 6 cycloalkyl, aryl, heterocyclyl, heteroaryl and C 1 -C 4 alkyl in each R 15 , R 16 and R 17 can optionally be substituted with halo, CN, C 1 -C 4 alkyl, OH, C 1 -C 4 alkoxy, COOH, C(O)OC 1 -C 4 alkyl, NH 2 , C 1 -C 4 alkylamino, or C 1 -C 4 dialkylamino.

3. The compound of claim 2 , wherein R 1 is an optionally substituted indanyl, an optionally substituted indolyl, an optionally substituted thienyl, an optionally substituted 2,3,4,9-tetrahydro-1H-carbazolyl.

4. The compound of claim 3 , wherein R 1 is 2,3-dimethyl-1H-indol-5-yl, 4,5-dimethyl-thien-2-yl, or 2,3,4,9-tetrahydro-1H-carbazol-6-yl.

5. The compound of claim 1 , wherein X 1 is a group represented by the following formula:

6. The compound of claim 2 , wherein Y is (CH(R g )) m , O, N(OR k ), NR k , or absent.

7. The compound of claim 6 , wherein Y is NR k and R k is H or a lower alkyl.

8. The compound of claim 6 , wherein each of R 2 and R 4 is independently, H or an alkyl.

9. The compound of claim 6 , wherein R 3 is H, an optionally substituted alkyl, an optionally substituted aryl, an optionally substituted heteroaryl, an optionally substituted cycloalkyl, an optionally substituted cyclyl, an optionally substituted heterocycloalkyl, an optionally substituted heterocyclyl, cyano, halo, OR k , or NR h R j .

10. The compound of claim 9 , wherein R 3 is —OR k or —NR h R j , and R f , R h and R j are each, independently, H or alkyl.

11. The compound of claim 6 , wherein n is 0, 1, 2, or 3.

12. The compound of claim 6 , wherein G is —C(O)NHNH—, —NHNHC(O)—, —C(O)NR k NR k —, —NR k NR k C(O)—, —CH═N—NH—, —NH—N═CH—CR g ═N—NR k —, —NR k —N═CR g —, —NHNH—, —NR k NR k —, —NHO— —O—NH—, —O—NR k —, —NR k —O—, —CH═N—O—, —O—N═CH—, —CR g ═N—O—, —O—N═CR g —, —O—C(O)—NH—, —O—C(O)—NR k —, —O—C(S)—NH—, —NH—C(S)—O—, —O—C(S)—NR k —, —NR k —C(S)—O—, —NH—C(NH)—NH—, —NR k —C(NH)—NH—, —NR k —C(NR)—NH—, —NH—C(N(CN))—NH—, —NH—C(NSO 2 R c )—NH—, —NR k —C(NSO 2 R c )—NH—, —NH—C(NNO 2 )—NH—, —NH—C(NC(O)R c )—NH—,—NH—C(O)—NH—, —NR k —C(O)—NR k —, —NH—C(S)—NH— and —NR k —C(S)—NR k —, —NH—S(O) 2 —NH—, —NR k —S(O) 2 —NR k —, —NR k —S(O) 2 —O—, —P(O)(R c )—, —P(O)(R c )—O—, —P(O)(R c )—NR k —, -Cyclyl-, -Heterocyclyl-, -Aryl-, -Heteroaryl-, -Heteroarylalkyl-, -Heteroaryl-NH—, -Heteroaryl-S-, -Heteroarylalkyl-O—, —C(N—CN)—NH—, —Si(OH) 2 —, —B(OH)—, —C(NH)—NR k —, —NR k —CH 2 —C(O)—, —C(O)—ONR k —, —C(O)—NR k O—, —C(S)—ONR k —, —C(S)—NR k O—, —C(NR)—ONR k —, —C(NR)—NR k O—, —OS(O) 2 —NR k NR k —, —OC(O)—NR k NR k —, —OC(S)—NR k NR k —, —OC(NR)—NR k NR k —, —NR k NR k S(O) 2 O—, —NR k NR k C(S)O—, —NR k NR k C(NR)O—, —OP(O)(R c )O—, —NR k P(O)(R c )O—, —OP(O)(R c )N(R k )—, —NR k P(O)(R c )N(R k )—, —P(O)(R c )O—, —P(O)(R c )NR k —, —NR k P(O)(R c )—, —OP(O)(R c )—, —O-alkyl-heterocyclyl-N(R c )—, —NR k CHR g C(O)NR k CHR g C(O)—, —NR g CHR g C(O)—, —NR k C(O)CHR g —, —C(O)NR k CHR g C(O)—, or absent.

13. The compound of claim 6 , wherein G is absent.

14. A compound selected from the group consisting of:

(1) Diisopropyl-{4-methoxy-6-[N′-(1-methyl-1H-indol-3-ylmethylene)-hydrazino]-[1,3,5]triazin-2-yl}-amine;

(2) {4-[N′-(1H-Indol-3-ylmethylene)-hydrazino]-6-methoxy-[1,3,5]triazin-2-yl}-diisopropyl-amine;

(3) Diisopropyl-{4-methoxy-6-[N′-(7-methyl-1H-indol-3-ylmethylene)-hydrazino]-[1,3,5]triazin-2-yl}-amine;

(4) {4[N′-(5-Fluoro-1H-indol-3-ylmethylene)-hydrazino]-6-methoxy-[1,3,5]triazin-2-yl}-diisopropyl-amine;

(5) 1-{3-[(4-Diisopropylamino-6-methoxy-[1,3,5]triazin-2-yl)-hydrazonomethyl]-indol -1-yl}-ethanone;

(6) [4-[N′-(1H-Indol)-3-ylmethylene)-hydrazino]-6-(2-pyridin-2-yl-ethoxy)-[1,3,5]triazin-2-ylamino]-acetic acid methyl ester;

(7) N-{4-[2-(3,4-Dimethoxy-phenyl)-ethoxy]-6-thiazolidin-3-yl[1,3,5]triazin-2-yl}-N′-(1H-indol-3-ylmethylene)-hydrazine;

(8) N-[4-(1,4-Dioxa-8-aza-spiro[4.5]dec-8-yl)-6-(2-pyridin-2-yl-ethoxy)-[1,3,5]triazin-2-yl]-N′-(1H-indol-3-ylmethylene)-hydrazine;

(9) [4-[N′-(1H-Indol-3-ylmethylene)-hydrazino]-6-(2-pyridin-2-yl-ethoxy)-[1,3,5]triazin-2-ylamino]-acetonitrile;

(10) N-(1H-Indol-3-ylmethylene)-N′-[4-(2-pyridin-2-yl-ethoxy)-6-(tetrahydro-pyran-4-yloxy)-[1,3,5]triazin-2-yl]-hydrazine;

(11) 1-[4-[N′-(1H-Indol-3-ylmethylene)-hydrazino]-6-(2-pyridin-2-yl-ethoxy)-[1,3,5]triazin-2-yl]-piperidin-4-one;

(12) N-(3-Methyl-benzylidene)-N′-[6-piperidin-1-yl-2-(2-pyridin-2-yl-ethoxy)-pyrimidin-4-yl]-hydrazine;

(13) Bis-(2-methoxy-ethyl)-[6-[N′-(3-methyl-benzylidene)-hydrazino]-2-(2-pyridin-2-yl-ethoxy)-pyrimidin-4-yl]-amine;

(14) [2-(3,4-Dimethoxy-phenyl)-ethyl]-{4-methyl-6-[N′-(3-methyl-benzylidene)-hydrazino]-pyrimidin-2-yl}-amine;

(15) {2-[2-(3,4-Dimethoxy-phenyl)-ethoxy]-6-[N′-(3-methyl-benzylidene)-hydrazino]-pyrimidin-4-yl}-dimethyl-amine;

(16) {6-[2-(3,4-Dimethoxy-phenyl)-ethoxy]-2-[N′-(3-methyl-benzylidene)-hydrazino]-pyrimidin-4-yl}-dimethyl-amine;

(17) [2-(3,4-Dimethoxy-phenyl)-ethyl]-{4-[N′-(3-methyl-benzylidene)-hydrazino]-pyrimidin-2-yl}-amine;

(18) Dimethyl-[2-[N′-(3-methyl-benzylidene)-hydrazino]-6-(2-morpholin-4-yl-ethoxy)-pyridin-4-yl]-amine;

(19) 2,6-Bis-[N′-(3-methyl-benzylidene)-hydrazino]-pyrimidin-4-ylamine;

(20) N-{4-[2-(3,4-Dimethoxy-phenyl)-ethoxy]-6-thiophen-3-yl-[1,3,5]triazin-2-yl}-N′-isopropylidene-hydrazine;

(21) N-{4-[2-(3,4-Dimethoxy-phenyl)-ethoxy]-6-imidazol-1-yl-[1,3,5]triazin-2-yl}-N′-(3-methyl-benzylidene)-hydrazine;

(22) N-{4-Chloro-6-[2-(3,4-dimethoxy-phenyl)-ethoxy]-[1,3,5]triazin-2-yl}-N′-(3-methyl-benzylidene)-hydrazine;

(23) N-{4-[2-(3,4-Dimethoxy-phenyl)-ethoxy]-6-phenyl-[1,3,5]triazin-2-yl}-N′-(3-methyl-benzylidene)-hydrazine;

(24) N-{4-[2-(3,4-Dimethoxy-phenyl)-ethoxy]-6-thiophen-3-yl-[1,3,5]triazin-2-yl}-N′-(3-methyl-benzylidene)-hydrazine;

(25) N-(3-Methyl-benzylidene)-N′-[2-(2-pyridin-2-yl-ethoxy)-6-pyrrolidin-1-yl-pyrimidin-4-yl]-hydrazine;

(26) N-[6-Azetidin-1-yl-2-(2-pyridin-2-yl-ethoxy)-pyrimidin-4-yl]-N′-(3-methyl-benzylidene)-hydrazine;

(27) 3-{6-Dimethylamino-2-[N′-(3-methyl-benzylidene)-hydrazino]-pyrimidin-4-yl}-propan-1-ol;

(28) (4-Nitro-phenyl)-carbamic acid 3-{6-dimethylamino-2-[N′-(3-methyl-benzylidene)-hydrazino]-pyrimidin-4-yl}-propyl ester;

(29) (4-Trifluoromethyl-phenyl)-carbamic acid 3-{6-dimethylamino-2-[N′-(3-methyl-benzylidene)-hydrazino]-pyrimidin-4-yl}-propyl ester;

(30) Diethyl-[6-[N′-(3-methyl-benzylidene)-hydrazino]-2-(2-morpholin-4-yl-ethoxy)-pyrimidin-4-yl]-amine;

(31) (2-Methoxy-ethyl)-methyl-[6-[N′-(3-methyl-benzylidene)-hydrazino]-2-(2-morpholin-4-yl-ethoxy)-pyrimidin-4-yl]-amine;

(32) 6-(2,3-Dimethyl-1H-indol-5-ylamino)-2-(2-morpholin-4-yl-ethoxy)-pyrimidine-4-carboxylic acid methyl ester;

(33) 6-(2,3-Dimethyl-1H-indol-5-ylamino)-2-(2-morpholin-4-yl-ethoxy)-pyrimidine-4-carboxylic acid dimethylamide;

(34) [6-(2,3-Dimethyl-1H-indol-5-ylamino)-2-(2-morpholin-4-yl-ethoxy)-pyrimidin-4-yl]-morpholin-4-yl-methanone;

(35) 4-(2,3-Dimethyl-1H-indol-5-ylamino)-6-(2-morpholin-4-yl-ethoxy)-pyrimidine-2-carboxylic acid methyl ester;

(36) N-(1H-Indol-3-ylmethylene)-N′-[2-(2-pyridin-2-yl-ethoxy)-6-thiazolidin-3-yl-pyrimidin-4-yl]-hydrazine;

(37) N-(1H-Indol-3-ylmethylene)-N′-[2-(2-morpholin-4-yl-ethoxy)-6-thiazolidin-3-yl-pyrimidin-4-yl]-hydrazine;

(38) N-(3-Methyl-benzylidene)-N′-[2-(2-morpholin-4-yl-ethoxy)-6-thiazolidin-3-yl-pyrimidin-4-yl]-hydrazine;

(39) 3-(2-{4-[N′-(3-Methyl-benzylidene)-hydrazino]-6-thiazolidin-3-yl-pyrimidin-2-yloxy}-ethyl)-oxazolidin-2-one;

(40) 4-Methyl-2-{[2-(2-methylamino-ethoxy)-6-thiazolidin-3-yl-pyrimidin-4-yl]-hydrazonomethyl}-phenol;

(41) N-(3-Methyl-benzylidene)-N′-[6-(2-morpholin-4-yl-ethoxy)-4-thiazolidin-3-yl-pyridin-2-yl]-hydrazine;

(42) N-(3-Methyl-benzylidene)-N′-[2-(2-morpholin-4-yl-ethoxy)-6-thiazolidin-3-yl-pyridin-4-yl]-hydrazine;

(43) (2,3-Dimethyl-1H-indol-6-yl)-[2-(2-morpholin-4-yl-ethoxy)-6-thiazolidin-3-yl-pyrimidin-4-yl]-amine;

(44) 2-(2-Morpholin-4-yl-ethoxy)-6-thiazolidin-3-yl-pyrimidine-4-carboxylic acid (2,3-dimethyl-1H-indol-5-yl)-amide;

(45) 3-(2-{4-Diethylamino-6-[N′-(3-methyl-benzylidene)-hydrazino]-pyrimidin-2-yloxy}-ethyl)-oxazolidin-2-one;

(46) Diethyl-{2-(2-methylamino-ethoxy)-6-[N′-(3-methyl-benzylidene)-hydrazino]-pyrimidin-4-yl}-amine;

(47) 1-{4-Diethylamino-6-[N′-(3-methyl-benzylidene)-hydrazino]-pyrimidin-2-yloxy}-2-methyl-propan-2-ol;

(48) Diethyl-[6[N′-(3-methyl-benzylidene)-hydrazino]-2-(2-pyridin-2-yl-ethoxy)-pyrimidin-4-yl]-amine;

(49) 2-{[6-Diethylamino-2-(2-morpholin-4-yl-ethoxy)-pyrimidin-4-yl]-hydrazonomethyl}-4-methyl-phenol;

(50) Diethyl-[6-[N′-(1H-indol-3-ylmethylene)-hydrazino]-2-(2-morpholin-4-yl-ethoxy)-pyrimidin-4-yl]-amine;

(51) Diethyl-[4-[N′-(3-methyl-benzylidene)-hydrazino]-6-(2-morpholin-4-yl-ethoxy)-[1,3,5]triazin-2-yl]-amine;

(52) Diethyl-[2-[N′-(3-methyl-benzylidene)-hydrazino]-6-(2-morpholin-4-yl-ethoxy)-pyridin-4-yl]-amine;

(53) Diethyl-[6-[N′-(3-methyl-benzylidene)-hydrazino]-4-(2-morpholin-4-yl-ethoxy)-pyridin-2-yl]-amine;

(54) 6-Diethylamino-2-(2-morpholin-4-yl-ethoxy)-pyrimidine-4-carboxylic acid (2,3-imethyl-1H-indol-5-yl)-amide;

(55) 6-Diethylamino-2-(2-morpholin-4-yl-ethoxy)-4-[(2,3-dimethy-1H-indol-5-yl)-amino]-pyrimidine;

(56) 3-(2-{4-[(2-Methoxy-ethyl)-methyl-amino]-6-[N′-(3-methyl-benzylidene)-hydrazino]-pyrimidin-2-yloxyl}-ethyl)-oxazolidin-2-one;

(57) (2-Methoxy-ethyl)-methyl-{2-(2-methylamino-ethoxy)-6-[N′-(3-methyl-benzylidene)-hydrazino]-pyrimidin-4-yl}-amine;

(58) 1-{4-[(2-Methoxy-ethyl)-methyl-amino]-6-[N′-(3-methyl-benzylidene)-hydrazino]-pyrimidin-2-yloxy}-2-methyl-propan-2-ol;

(59) (2-Methoxy-ethyl)-methyl-[4-[N′-(3-methyl-benzylidene)-hydrazino]-6-(2-morpholin-4-yl-ethoxy)-[1,3,5]triazin-2-yl]-amine;

(60) (2-Methoxy-ethyl)-methyl-[2-[N′-(3-methyl-benzylidene)-hydrazino]-6-(2-morpholin-4-yl-ethoxy)-pyridin-4-yl]-amine;

(61) (2-Methoxy-ethyl)-methyl-[6-[N′-(3-methyl-benzylidene)-hydrazino]-4-(2-morpholin-4-yl-ethoxy)-pyridin-2-yl]-amine;

(62) 2-{[6-[(2-Methoxy-ethyl)-methyl-amino]-2-(2-morpholin-4-yl-ethoxy)-pyrimidin-4-yl]-hydrazonomethyl}-4-methyl-phenol;

(63) [6-[N′-(1H-Indol-3-ylmethylene)-hydrazino]-2-(2-morpholin-4-yl-ethoxy)-pyrimidin-4-yl]-(2-methoxy-ethyl)-methyl-amine;

(64) 4-[(2-Methoxy-ethyl)-methyl-amino]-6-(2-morpholin-4-yl-ethoxy)-[1,3,5]triazine-2-carboxylic acid (2,3-dimethyl-1H-indol-5-yl)-amide;

(65) N-(2,3-Dimethyl-1H-indol-5-yl)-N′-(2-methoxy-ethyl)-N′-methyl-6-(2-morpholin-4-yl-ethoxy)-[1,3,5]triazine-2,4-diamine;

(66) Dimethyl-[6-[N′-(3-methyl-benzylidene)-hydrazino]-2-(2-morpholin-4-yl-ethoxy)-pyrimidin-4-yl]-amine;

(67) 3-(2-{4-Dimethylamino-6-[N′-(3-methyl-benzylidene)-hydrazino]-pyrimidin-2-yloxy}-ethyl)-oxazolidin-2-one;

(68) Dimethyl-{2-(2-methylamino-ethoxy)-6-[N′-(3-methyl-benzylidene)-hydrazino]-pyrimidin-4-yl}-amine;

(69) 1-{4-Dimethylamino-6-[N′-(3-methyl-benzylidene)-hydrazino]-pyrimidin-2-yloxy}-2-methyl-propan-2-ol;

(70) Dimethyl-[6[N′-(3-methyl-benzylidene)-hydrazino]-2-(2-pyridin-2-yl-ethoxy)-pyrimidin-4-yl]-amine;

(71) 2-{[6-Dimethylamino-2-(2-morpholin-4-yl-ethoxy)-pyrimidin-4-yl]-hydrazonomethyl}-4-methyl-phenol;

(72) [6-[N′-(2-Amino-5-methyl-benzylidene)-hydrazino]-2-(2-morpholin-4-yl-ethoxy)-pyrimidin-4-yl]-dimethyl-amine;

(73) [6-[N′-(1H-Indol-3-ylmethylene)-hydrazino]-2-(2-morpholin-4-yl-ethoxy)-pyrimidin-4-yl]-dimethyl-amine;

(74) Dimethyl-[4-[N′-(3-methyl-benzylidene)-hydrazino]-6-(2-morpholin-4-yl-ethoxy)-[1,3,5]triazin-2-yl]-amine;

(75) Dimethyl-[6-[N′-(3-methyl-benzylidene)-hydrazino]-4-(2-morpholin-4-yl-ethoxy)-pyridin-2-yl]-amine;

(76) 6-Dimethylamino-2-(2-morpholin-4-yl-ethoxy)-pyrimidine-4-carboxylic acid (2,3-dimethyl-1H-indol-5-yl)-amide;

(77) 6-Dimethylamino-2-(2-morpholin-4-yl-ethoxy)-4-[(2,3-dimethyl-1H-indol-5-yl)-amino] pyrimidine;

(78) 6-[N′-(3-Methyl-benzylidene)-hydrazino]-2-(2-morpholin-4-yl-ethoxy)-pyrimidin-4-ylamine;

(79) 3-(2-{4-Amino-6-[N′-(3-methyl-benzylidene)-hydrazino]-pyrimidin-2-yloxy}-ethyl)-oxazolidin-2-one;

(80) 2-(2-Methylamino-ethoxy)-6-[N′-(3-methyl-benzylidene)-hydrazino]-pyrimidin-4-ylamine;

(81) 6-[N′-(3-Methyl-benzylidene)-hydrazino]-2-(2-pyridin-2-yl-ethoxy)-pyrimidin-4-ylamine;

(82) 2-{[6-Amino-2-(2-morpholin-4-yl-ethoxy)-pyrimidin-4-yl]-hydrazonomethyl}-4-methyl-phenol;

(83) 6-[N′-(2-Amino-5-methyl-benzylidene)-hydrazino]-2-(2-morpholin-4-yl-ethoxy)-pyrimidin-4-ylamine;

(84) 6-[N′-(1H-Indol-3-ylmethylene)-hydrazino]-2-(2-morpholin-4-yl-ethoxy)-pyrimidin-4-ylamine;

(85) 1-{4-Amino-6-[N′-(3-methyl-benzylidene)-hydrazino]-pyrimidin-2-yloxy}-2-methyl-propan-2-ol;

(86) 2-[N′-(3-Methyl-benzylidene)-hydrazino]-6-(2-morpholin-4-yl-ethoxy)-pyridin-4-ylamine;

(87) 6-[N′-(3-Methyl-benzylidene)-hydrazino]-4-(2-morpholin-4-yl-ethoxy)-pyridin-2-ylamine;

(88) 4-[N′-(3-Methyl-benzylidene)-hydrazino]-6-(2-morpholin-4-yl-ethoxy)-[1,3,5]triazin-2-ylamine;

(89) 2-Amino-6-(2-morpholin-4-yl-ethoxy)-pyrimidine-4-carboxylic acid (2,3-dimethyl-1H-indol-5-yl)-amide;

(90) N4-(2,3-Dimethyl-1H-indol-5-yl)-6-(2-morpholin-4-yl-ethoxy)-pyrimidine-2,4-diamine;

(91) N-[4-Imidazol-1-yl-6-(2-morpholin-4-yl-ethoxy)-[1,3,5]triazin-2-yl]-N′-(3-methyl-benzylidene)-hydrazine;

(92) 3-(2-{4-Imidazol-1-yl-6-[N′-(3-methyl-benzylidene)-hydrazino]-pyrimidin-2-yloxy}-ethyl)-oxazolidin-2-one;

(93) (2-{4-Imidazol-1-yl-6-[N′-(3-methyl-benzylidene)-hydrazino]-pyrimidin-2-yloxy}-ethyl)-methyl-amine;

(94) 1-{4-Imidazol-1-yl-6-[N′-(3-methyl-benzylidene)-hydrazino]-pyrimidin-2-yloxy}-2-methyl-propan-2-ol;

(95) N-[4-Imidazol-1-yl-6-(2-morpholin-4-yl-ethoxy)-pyridin-2-yl]-N′-(3-methyl-benzylidene)-hydrazine;

(96) 2-{[6-Imidazol-1-yl-2-(2-morpholin-4-yl-ethoxy)-pyrimidin-4-yl]-hydrazonomethyl}-4-methyl-phenol;

(97) N-[6-Imidazol-1-yl-2-(2-morpholin-4-yl-ethoxy)-pyrimidin-4-yl]-N′-(1H-indol-3-ylmethylene)-hydrazine;

(98) 2-Imidazol-1-yl-6-(2-morpholin-4-yl-ethoxy)-pyrimidine-4-carboxylic acid (2,3-dimethyl-1H-indol-5-yl)-amide;

(99) (2,3-Dimethyl-1H-indol-5-yl)-[2-imidazol-1-yl-6-(2-morpholin-4-yl-ethoxy)-pyrimidin-4-yl]-amine;

(100) 1-[2,4′]Bipyridinyl-6-yl-3-indan-5-yl-urea;

(101) 4-(2-Morpholin-4-yl-ethoxy)-[2,4′]bipyridinyl-6-carboxylic acid (2,3-dimethyl-1H-indol-5-yl)-amide;

(102) 4-[(2-Methoxy-ethyl)-methyl-amino]-[2,4′]bipyridinyl-6-carboxylic acid (2,3-dimethyl-1H-indol-5-yl)-amide;

(103) 3′-Fluoro-[2,4′]bipyridinyl-6-carboxylic acid (2,3-dimethyl-1H-indol-5-yl)-amide;

(104) 6-Pyrimidin-5-yl-pyridine-2-carboxylic acid (2,3-dimethyl-1H-indol-5-yl)-amide;

(105) 6-Thiophen-3-yl-pyridine-2-carboxylic acid (2,3-dimethyl-1H-indol-5-yl)-amide;

(106) [2,3′]Bipyridinyl-6-carboxylic acid (2,3-dimethyl-1H-indol-5-yl)-amide;

(107) 2′-Fluoro-[2,4′]bipyridinyl-6-carboxylic acid (2,3-dimethyl-1H-indol-5-yl)-amide;

(108) 6-(1H-Pyrazol-4-yl)-pyridine-2-carboxylic acid (2,3-dimethyl-1H-indol-5-yl)-amide;

(109) (E)-4-(2-(4-(2-(3-methylbenzylidene)hydrazinyl)-6-(pyridin-4-yl)pyrimidin-2-yloxy)ethyl)morpholine;

(110) (E)-4-methyl-2-((2-(2-(2-morpholinoethoxy)-6-(pyridin-4-yl)pyrimidin-4-yl)hydrazono)methyl)phenol;

(111) (E)-4-(2-(4-(2-(3,4-dimethylbenzylidene)hydrazinyl)-6-(pyridin-4-yl)pyrimidin-2-yloxy)ethyl)morpholine;

(112) (E)-4-(2-(4-(2-((4,5-dimethylthiophen-2-yl)methylene)hydrazinyl)-6-(pyridin-4-yl)pyrimidin-2-yloxy)ethyl)morpholine;

(113) (E)-N-(2-methoxyethyl)-N-methyl-4-(2-(3-methylbenzylidene)hydrazinyl)-6-(pyridin-4-yl)pyrimidin-2-amine;

(114) (E)-2-((2-(2-((2-methoxyethyl)(methyl)amino)-6-(pyridin-4-yl)pyrimidin-4-yl)hydrazono)methyl)-4-methylphenol;

(115) (E)-4-(2-(3,4-dimethylbenzylidene)hydrazinyl)-N-(2-methoxyethyl)-N-methyl-6-(pyridin-4-yl)pyrimidin-2-amine;

(116) (E)-4-(2-((4,5-dimethylthiophen-2-yl)methylene)hydrazinyl)-N-(2-methoxyethyl)-N-methyl-6-(pyridin-4-yl)pyrimidin-2-amine;

(117) (E)-2-(methyl(4-(2-(3-methylbenzylidene)hydrazinyl)-6-(pyridin-4-yl)pyrimidin-2-yl)amino)ethanol;

(118) (E)-2-((4-(2-(3,4-dimethylbenzylidene)hydrazinyl)-6-(pyridin-4-yl)pyrimidin-2-yl)(methyl)amino)ethanol;

(119) (E)-2-((2-(2-((2-hydroxyethyl)(methyl)amino)-6-(pyridin-4-yl)pyrimidin-4-yl)hydrazono)methyl)-4-methylphenol;

(120) (E)-2-((4-(2-((4,5-dimethylthiophen-2-yl)methylene)hydrazinyl)-6-(pyridin-4-yl)pyrimidin-2-yl)(methyl)amino)ethanol;

(121) (E)-O-methyl-N-(4-(2-(3-methylbenzylidene)hydrazinyl)-6-(pyridin-4-yl)pyrimidin-2-yl)hydroxylamine;

(122) (E)-N-(4-(2-(3,4-dimethylbenzylidene)hydrazinyl)-6-(pyridin-4-yl)pyrimidin-2-yl)-O-methylhydroxylamine;

(123) (E)-2-((2-(2-(methoxyamino)-6-(pyridin-4-yl)pyrimidin-4-yl)hydrazono) methyl)-4-methylphenol;

(124) (E)-N-(4-(2-((4,5-dimethylthiophen-2-yl)methylene)hydrazinyl)-6-(pyridin-4-yl)pyrimidin-2-yl)-O-methylhydroxylamine;

(125) (E)-4-(2-(3-methylbenzylidene)hydrazinyl)-2-(2-(pyridin-2-yl)ethoxy)-6-(pyridin-4-yl)pyrimidine;

(126) (E)-4-(2-(3,4-dimethylbenzylidene)hydrazinyl)-2-(2-(pyridin-2-yl)ethoxy)-6-(pyridin-4-yl)pyrimidine;

(127) (E)-4-methyl-2-((2-(2-(2-(pyridin-2-yl)ethoxy)-6-(pyridin-4-yl)pyrimidin-4-yl)hydrazono)methyl)phenol;

(128) (E)-4-(2-((4,5-dimethylthiophen-2-yl)methylene)hydrazinyl)-2-(2-(pyridin-2-yl)ethoxy)-6-(pyridin-4-yl)pyrimidine;

(129) (E)-4-(2-(4-(2-(3-methylbenzylidene)hydrazinyl)-6-(pyridin-4-yl)-1,3,5-triazin-2-yloxy)ethyl)morpholine;

(130) (E)-4-(2-(4-(2-((4,5-dimethylthiophen-2-yl)methylene)hydrazinyl)-6-(pyridin-4-yl)-1,3,5-triazin-2-yloxy)ethyl)morpholine;

(131) (E)-N-(2-methoxyethyl)-N-methyl-4-(2-(3-methylbenzylidene)hydrazinyl)-6-(pyridin-4-yl)-1,3,5-triazin-2-amine;

(132) (E)-4-(2-((4,5-dimethylthiophen-2-yl)methylene)hydrazinyl)-N-(2-methoxyethyl)-N-methyl-6-(pyridin-4-yl)-1,3,5-triazin-2-amine;

(133) (E)-O-methyl-N-(4-(2-(3-methylbenzylidene)hydrazinyl)-6-(pyridin-4-yl)-1,3,5-triazin-2-yl)hydroxylamine;

(134) (E)-N-(4-(2-((4,5-dimethylthiophen-2-yl)methylene)hydrazinyl)-6-(pyridin-4-yl)-1,3,5-triazin-2-yl)-O-methylhydroxylamine;

(135) (E)-4-(2-(6-(2-(3-methylbenzylidene)hydrazinyl)-4,4′-bipyridin-2-yloxy)ethyl)morpholine;

(136) (E)-4-(2-(6-(2-((4,5-dimethylthiophen-2-yl)methylene)hydrazinyl)-4,4′-bipyridin-2-yloxy)ethyl)morpholine;

(137) (E)-2-(methyl(6-(2-(3-methylbenzylidene)hydrazinyl)-4,4′-bipyridin-2-yl)amino)ethanol;

(138) (E)-2-((6-(2-(3,4-dimethylbenzylidene)hydrazinyl)-4,4′-bipyridin-2-yl)(methyl)amino)ethanol;

(139) (E)-6-(2-((4,5-dimethylthiophen-2-yl)methylene)hydrazinyl)-N-(2-methoxyethyl)-N-methyl-4,4′-bipyridin-2-amine;

(140) (E)-6-(2-((4,5-dimethylthiophen-2-yl)methylene)hydrazinyl)-N-(2-methoxyethyl)-N-methyl-4,4′-bipyridin-2-amine;

(141) (E)-4-(2-(6-(2-(3-methylbenzylidene)hydrazinyl)-2-(pyridin-4-yl)pyrimidin-4-yloxy)ethyl)morpholine;

(142) (E)-4-(methoxymethyl)-6-(2-(3-methylbenzylidene)hydrazinyl)-2-(pyridin-4-yl)pyrimidine;

(143) (E)-4-(2-(3-methylbenzylidene)hydrazinyl)-6-(pyridin-3-yl)-1,3,5-triazin-2-amine;

(144) 1-(4-(methylthio)-6-(pyridin-4-yl)-1,3,5-triazin-2-yl)-3-m-tolylurea;

(145) 1-(4-(methylthio)-6-(pyridin-3-yl)-1,3,5-triazin-2-yl)-3-m-tolylurea;

(146) N-(2,3-dimethyl-1H-indol-5-yl)-2,4′-bipyridine-6-carboxamide;

(147) N-(2,3-dimethyl-1H-indol-5-yl)-2-(dimethylamino)-6-(2-morpholino ethylamino) pyrimidine-4-carboxamide; and

(148) N-(2,3-dimethyl-1H-indol-5-yl)-6-(2-morpholinoethylamino)-2-(thiazolidin-3-yl)pyrimidine-4-carboxamide;

or pharmaceutically acceptable salts thereof.

15. A pharmaceutical composition, comprising a pharmaceutically acceptable carrier and a compound of claim 1 .

Assignments (5)
SECURITY INTEREST Recorded Feb 18, 2026
From: ORPHAI THERAPEUTICS INC.
To: ACADIA WOODS PARTNERS, LLC, AS AGENT
Reel/Frame 074910/0274 →
SECURITY INTEREST Recorded Jul 17, 2025
From: MADRIGAL PHARMACEUTICALS, INC.
To: LSI FINANCING LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 072038/0693 →
SECURITY INTEREST Recorded Jun 23, 2025
From: ORPHAI THERAPEUTICS INC.
To: ACADIA WOODS PARTNERS, LLC
Reel/Frame 071697/0788 →
CHANGE OF NAME Recorded May 3, 2021
From: SYNTA PHARMACEUTICALS CORP.
To: MADRIGAL PHARMACEUTICALS, INC.
Reel/Frame 056121/0785 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 10, 2006
From: SUN, LIJUN; ZHANG, SHIJIE; KOYA, KEIZO; CHIMMANAMADA, DINESH; LI, HAO; JAMES, DAVID; KOSTIK, ELENA
To: SYNTA PHARMACEUTICALS CORP.
Reel/Frame 017255/0416 →
Continuity (2)
Provisional Application 60627001 · Nov 10, 2004
Related Publication 20060122156A1 · Jun 8, 2006